TriSpan-backed Real Good Dental buys Enamel Dental Group

• Enamel Dental Group has grown rapidly since its founding in 2017 with the group now comprising 68 surgeries within 18 trading practices across the UK
• Real Good Dental’s acquisition of Enamel Dental Group is part of a wider development plan for the group as it looks to expand its presence in the UK
• The Enamel Dental Group management team will run the group while joining the wider RGD family, which now comprises 82 practices across England and Scotland

London-based TriSpan’s portfolio company Real Good Dental (RGD) announced on 4 August that it has bought the Enamel Dental Group, marking RGD’s move into England.

The Enamel Dental Group is a dental group comprising 68 surgeries within 18 trading practices across the UK that has grown rapidly through a focused acquisition strategy. The group, headquartered in London, was established in 2017.

RGD is headquartered in Edinburgh and has been a TriSpan portfolio company since June 2021. TriSpan made an initial investment in the company with the backing of Keyhaven Capital.

“We are very proud to welcome the Enamel Dental Group into the RGD family and are looking forward to working with their teams in continuing to develop Enamel and the wider group,” said Fady Michel Abouchalache and Joseph-Patrick Dib, partners at TriSpan.

RGD’s purchase of Enamel Dental Group sees the enlarged group grow to 82 practices across Scotland and England. The Enamel Dental Group management team will run the firm while joining forces with the wider RGD family.

“Enamel Dental is a fantastic group of dental practices with a best-in-class management team,” said Jagdeep Singh Hans, CEO of Real Good Dental. “Everyone at RGD is very excited about what the future holds for the wider group.”

TriSpan, founded in 2015, is a private equity firm with offices in London and New York. It looks to invest in lower mid-cap companies in North America and Europe with annual revenues ranging typically from $20 million to $100 million and $2 million to $20 million in EBITDA.

Keyhaven Capital, which continues to support TriSpan and RGD, is a specialist secondaries private equity firm that invests in European lower-mid market companies. Since it was founded in 2003, London-based Keyhaven has invested or advised on over €2 billion and has made more than 60 secondaries investments in Europe.

“This transaction is an important landmark in RGD’s evolution and we are excited to support the group in its next stage of growth,” said Teddy Mouawad, partner at Keyhaven.